RecruitingPhase 4NCT06386991

Effect of Different Irrigation Solutions on Postoperative Pain and Lesion Healing

Evaluation of the Effects of Different Irrigation Solutions Used in Regenerative Endodontic Treatment of Lower Molars With Open Necrotic Apexes on Postoperative Pain and Lesion Healing


Sponsor

TC Erciyes University

Enrollment

39 participants

Start Date

Jan 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

In this study researchers plan to conduct, three different irrigation solutions that are responsible for the release of growth factors necessary for the success of regenerative endodontic treatments will be used. These solutions; Ethylene Diamine Tetra Acetic Acid (EDTA), Etidronic Acid and Citric Acid. The aim of this study is to evaluate the effect of different irrigation solutions used in regenerative endodontic treatment of necrotic open apex molar teeth on postoperative pain. Additionally, the healing of these teeth will be monitored for 1 year.


Eligibility

Min Age: 8 YearsMax Age: 15 Years

Inclusion Criteria4

  • Teeth with apical periodontitis
  • Teeth for which prosthetic restoration is not planned
  • Patients between the ages of 8-15 who do not have any significant health problems
  • Patients who are not accompanied by periodontal problems and have good oral hygiene

Exclusion Criteria3

  • Severely damaged teeth
  • If the tooth has previously undergone root canal treatment.
  • Use of antibiotics, anti-inflammatory and painkillers in the last two weeks

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERUsing ethylenediaminetetraacetic acid (EDTA), citric acid ((MONO/ANH) and etidronic acid (HEBP) to clean root canals during regenerative endodontic treatments

Regenerative endodontic treatment using different irrigation solutions


Locations(1)

Erciyes Üniversitesi Diş Hekimliği Fakültesi

Kayseri, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06386991


Related Trials